Skip to main content
Veterinary Medicines

TABERNIL SULFA

Authorised
  • Sulfaquinoxaline
  • Pyrimethamine
  • Sulfaquinoxaline sodium

Product identification

Medicine name:
TABERNIL SULFA
Active substance:
  • Sulfaquinoxaline
  • Pyrimethamine
  • Sulfaquinoxaline sodium
Target species:
  • Ornamental bird
Route of administration:
  • In drinking water use

Product details

Active substance and strength:
  • Sulfaquinoxaline
    40.00
    milligram(s)
    /
    1.00
    millilitre(s)
  • Pyrimethamine
    10.00
    milligram(s)
    /
    1.00
    millilitre(s)
  • Sulfaquinoxaline sodium
    40.00
    milligram(s)
    /
    1.00
    millilitre(s)
Pharmaceutical form:
  • Solution for use in drinking water
Withdrawal period by route of administration:
  • In drinking water use
    • Ornamental bird
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QP51AG53
Authorisation status:
  • Valid
Authorised in:
  • Spain
Available in:
  • Spain
Package description:

Additional information

Entitlement type:
  • Marketing Authorisation
Marketing authorisation holder:
  • Divasa Farmavic S.A.
Marketing authorisation date:
Manufacturing sites for batch release:
  • Divasa Farmavic S.A.
Responsible authority:
  • (AEMPS)
Authorisation number:
  • 963 ESP
Date of authorisation status change:

Documents

Summary of Product Characteristics

This document does not exist in this language (English). You can find it in another language below.
Spanish (PDF)
Published on: 8/11/2022

Package Leaflet

This document does not exist in this language (English). You can find it in another language below.
Spanish (PDF)
Published on: 8/11/2022

Labelling

This document does not exist in this language (English). You can find it in another language below.
Spanish (PDF)
Published on: 8/11/2022
How useful was this page?:
No votes yet
"Please do not include any personal data, such as your name or contact details. If you do, you consent to the processing of that data in accordance with EMA’s Privacy Statement concerning requests for information or access to documents. If you would like a reply from EMA, please Send a question to EMA instead."